SCHEMBL30002812

SCHEMBL30002812

C=C[C@]1(C)C[C@@H](n2ccc3c(N)ncnc32)[C@@H]2OC(C)(C)O[C@@H]21

nearest known ligand 0.46

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
PRMT5 O14744 18/20 0.46
WDR77 Q9BQA1 17/20 0.46
RAPGEF3 O95398 1/20 0.37
ADK P55263 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22494921 1.00 PRMT5 (0.46) PRMT5WDR77RAPGEF3ADK
SCHEMBL22494884 1.00 PRMT5 (0.46) PRMT5WDR77RAPGEF3ADK
SCHEMBL21682085 0.89 PRMT5 (0.40) PRMT5WDR77
SCHEMBL22495027 0.89 PRMT5 (0.40) PRMT5WDR77
SCHEMBL28477494 0.89 PRMT5 (0.40) PRMT5WDR77
SCHEMBL22494872 0.89 PRMT5 (0.40) PRMT5WDR77
SCHEMBL22495075 0.88 PRMT5 (0.40) PRMT5WDR77RAPGEF3ADK
SCHEMBL22494864 0.88 PRMT5 (0.35) PRMT5WDR77
SCHEMBL28476776 0.88 PRMT5 (0.35) PRMT5WDR77
SCHEMBL21682220 0.85 PRMT5 (0.40) PRMT5WDR77ADK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220363707-A1 PRMT5 INHIBITORS MERCK SHARP & DOHME CORP. (US) 2022-11-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220363707-A1 PRMT5 INHIBITORS PRMT5, PRMT1, PRMT3 PRMT5 1/4885WDR77 159/4885RAPGEF3 3608/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.